Fevery J - Search Results

1

Portal hypertension: from pathophysiology to clinical practice.

Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Laleman W, et al. Among authors: fevery j. Liver Int. 2005 Dec;25(6):1079-90. doi: 10.1111/j.1478-3231.2005.01163.x. Liver Int. 2005. PMID: 16343056 Review.

2

Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.

Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F. Laleman W, et al. Among authors: fevery j. Gastroenterology. 2007 Feb;132(2):709-19. doi: 10.1053/j.gastro.2006.12.041. Epub 2006 Dec 20. Gastroenterology. 2007. PMID: 17258737

3

MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure.

Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, Yap P, Fevery J, Roskams T, Pirenne J, Nevens F. Katoonizadeh A, et al. Among authors: fevery j. Liver Int. 2007 Apr;27(3):329-34. doi: 10.1111/j.1478-3231.2006.01429.x. Liver Int. 2007. PMID: 17355453

4

A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.

Laleman W, Omasta A, Van de Casteele M, Zeegers M, Vander Elst I, Van Landeghem L, Severi T, van Pelt J, Roskams T, Fevery J, Nevens F. Laleman W, et al. Among authors: fevery j. Hepatology. 2005 Dec;42(6):1382-90. doi: 10.1002/hep.20968. Hepatology. 2005. PMID: 16317694

5

A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.

Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F. Laleman W, et al. Among authors: fevery j. Eur J Clin Invest. 2006 Apr;36(4):242-9. doi: 10.1111/j.1365-2362.2006.01620.x. Eur J Clin Invest. 2006. PMID: 16620286

6

Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.

Lowette KF, Desmet K, Witters P, Laleman W, Verslype C, Nevens F, Fevery J, Cassiman DM. Lowette KF, et al. Among authors: fevery j. Eur J Gastroenterol Hepatol. 2010 May;22(5):564-71. doi: 10.1097/MEG.0b013e3283353df8. Eur J Gastroenterol Hepatol. 2010. PMID: 20042865

7

Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study.

Fevery J, Henckaerts L, Van Oirbeek R, Vermeire S, Rutgeerts P, Nevens F, Van Steenbergen W. Fevery J, et al. Liver Int. 2012 Feb;32(2):214-22. doi: 10.1111/j.1478-3231.2011.02575.x. Epub 2011 Jul 5. Liver Int. 2012. PMID: 21745316

8

The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U. Leuven.

Wilmer A, Nevens F, Evenepoel P, Hermans G, Fevery J. Wilmer A, et al. Among authors: fevery j. Liver. 2002;22 Suppl 2:52-5. doi: 10.1034/j.1600-0676.2002.00010.x. Liver. 2002. PMID: 12220305 Clinical Trial.

9

Halofuginone can worsen liver fibrosis in bile duct obstructed rats.

Van de Casteele M, Roskams T, Van der Elst I, van Pelt JF, Fevery J, Nevens F. Van de Casteele M, et al. Among authors: fevery j. Liver Int. 2004 Oct;24(5):502-9. doi: 10.1111/j.1478-3231.2004.0950.x. Liver Int. 2004. PMID: 15482349

10

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.

Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F. Laleman W, et al. Among authors: fevery j. Crit Care. 2006;10(4):R108. doi: 10.1186/cc4985. Crit Care. 2006. PMID: 16859530 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters